Reply: SARS-CoV-2 vaccination in inflammatory bowel disease patients with different biological agents.

Dai, Cong; Dong, Zi-Yuan; Wang, Yi-Nuo; Huang, Yu-Hong; Jiang, Min

Dai, Cong; Dong, Zi-Yuan; Wang, Yi-Nuo; Huang, Yu-Hong; Jiang, Min.

Dai C; gastroenterology, First Affiliated Hospital. China Medical University, china.
Dong ZY; Gastroenterology, First Affiliated Hospital. China Medical University.
Wang YN; Gastroenterology, First Affiliated Hospital. China Medical University.
Huang YH; Gastroenterology, First Affiliated Hospital. China Medical University.
Jiang M; Gastroenterology, First Affiliated Hospital. China Medical University.

Rev Esp Enferm Dig ; 1162023 Jan 12.

Artigo em Inglês | MEDLINE | ID: covidwho-2204329

ABSTRACT

ABSTRACT

We thank Dr Mungmunpuntipantip and colleague for their interest and thoughtful comments on our publication. The authors have highlighted several important considerations for the impact of SARS-CoV-2 vaccination in inflammatory bowel disease (IBD) patients with different biological agents. We fully agree with the author's point of view, and we also point out the limitations in our meta-analysis.

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: Disponível Coleções: Bases de dados internacionais Base de dados: MEDLINE Tipo de estudo: Revisões Tópicos: Vacinas Idioma: Inglês Assunto da revista: Gastroenterologia Ano de publicação: 2023 Tipo de documento: Artigo País de afiliação: Reed.2023.9438

Similares

MEDLINE

LILACS

LIS

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google